FDA-filed SPL labeling · retrieved through openFDA

Phendimetrazine

Phendimetrazine is a prescription stimulant used as a short-term aid for weight loss in adults with obesity who haven't responded to diet and exercise alone.

Brand name Melfiat
Drug class Sympathomimetic Amine Anorectic
Rx Schedule CIII Forms 2 Route Oral
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 15, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 17 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveDec 19, 2025
Clinical labels in scope 17
AvailabilityRx
Earliest approval/marketing year 1975
FDA-listed product records 65
Boxed warningNone found in compared labels
How we combine label and product data →
No current FDA shortage listed · checked Sep 23, 2026
Phendimetrazine at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Phendimetrazine is a short-term prescription stimulant used alongside a reduced-calorie diet for adults with obesity, when diet and exercise alone haven't been enough. It carries real risks — including pulmonary hypertension and potential for dependence — so it's meant to be used carefully, for only a few weeks, and never combined with other weight-loss drugs. Work closely with your prescriber to monitor your response and watch for any warning signs.

📖 Phendimetrazine: Patient Information Guide

A plain-language walkthrough of Phendimetrazine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for

Phendimetrazine tartrate is a prescription weight-loss aid approved for short-term use in adults with obesity. Here is what the available products are approved for:

  • Phendimetrazine Tartrate extended-release capsules are indicated for adults with a BMI of 30 or higher, or a BMI of 27 or higher when additional risk factors like high blood pressure, diabetes, or high cholesterol (hyperlipidemia) are present, who have not responded adequately to diet and exercise alone.
  • Phendimetrazine Tartrate tablets are indicated for adults with a BMI of 30 or higher who have not responded to diet and/or exercise alone.
  • Both forms are approved only as a short-term addition (a few weeks) to a calorie-restricted diet — not as a standalone solution.
  • Both forms are approved for use as monotherapy only — they must never be combined with other weight-loss drugs or stimulants.
⚙️How it works

Phendimetrazine is a sympathomimetic amine — a stimulant that mimics the effects of adrenaline-like chemicals in the body. It acts on the central nervous system similarly to amphetamines. It belongs to a class of drugs called anorectics, which are thought to reduce appetite, though the exact mechanism behind its weight-loss effect isn't fully established. Other actions on the brain or metabolism may also contribute.

The drug raises blood pressure and can increase heart rate as part of its stimulant effect. Tolerance to its appetite-suppressing action tends to develop within a few weeks, which is why it's only intended for short-term use.

💊How it's taken

Phendimetrazine tartrate comes in two oral forms with different dosing schedules — do not interchange them without your prescriber's guidance.

  • Tablets: Generally taken two to three times a day, about one hour before meals. Your prescriber will adjust the dose to find what works best for you.
  • Extended-release capsules (Phendimetrazine Tartrate): Taken once in the morning, 30 to 60 minutes before the morning meal. Do not take it later in the day, as it can disrupt sleep.

Always follow your prescriber's exact instructions. If you feel the medication is no longer working, do not increase your dose — talk to your doctor instead.

🤒Side effects — in detail

Like all stimulant medications, phendimetrazine can cause a range of side effects. Common ones include:

  • Dry mouth
  • Trouble sleeping (insomnia)
  • Restlessness, agitation, or overstimulation
  • Rapid or pounding heartbeat (palpitations or tachycardia)
  • Elevated blood pressure
  • Dizziness, tremor, or headache
  • Nausea, stomach pain, diarrhea, or constipation
  • Sweating, flushing, or blurred vision
  • Urinary frequency or changes in libido

More serious reactions — including pulmonary hypertension (high pressure in the lung arteries), heart valve problems, psychosis, and severe withdrawal after stopping suddenly — require immediate medical attention. Contact your doctor or seek emergency care if you notice chest pain, shortness of breath, fainting, leg swelling, hallucinations, or extreme mood changes.

⚠️Warnings & precautions
  • Pulmonary hypertension risk: Use of phendimetrazine has been linked to pulmonary hypertension — a rare but often fatal condition. The risk is significantly higher with more than three months of use. Stop taking it and see your doctor immediately if you develop shortness of breath during activity, chest pain, fainting, or leg swelling.
  • Heart valve concerns: Some anorectic drugs have been associated with heart valve damage. While no cases have been reported with phendimetrazine used alone, your doctor may recommend a cardiac evaluation before and during treatment.
  • Abuse and dependence potential: This medication is a stimulant with real potential for misuse. Do not take more than prescribed, and do not use it if you have a history of drug abuse.
  • Withdrawal: Stopping suddenly after prolonged high-dose use can cause severe fatigue and depression. Talk to your doctor before stopping.
  • Impaired alertness: Phendimetrazine can affect your ability to drive or operate machinery safely — be cautious until you know how it affects you.
  • Short-term use only: If you haven't lost at least 4 pounds after 4 weeks, your doctor should reassess whether to continue treatment.
🔀What it interacts with

Phendimetrazine interacts with several drugs and substances — always give your prescriber and pharmacist a full list of everything you take.

  • MAO inhibitors (e.g., phenelzine, tranylcypromine): Combining these with phendimetrazine can trigger a hypertensive crisis — a dangerous, potentially life-threatening spike in blood pressure. Do not take phendimetrazine within 14 days of stopping an MAO inhibitor.
  • Alcohol: Drinking alcohol while on phendimetrazine can cause an adverse reaction — avoid it.
  • Insulin and oral diabetes medications: Your need for diabetes medication may change while on phendimetrazine — monitor your blood sugar closely and tell your doctor.
  • Adrenergic neuron blocking drugs (some blood pressure medications): Phendimetrazine can reduce their blood-pressure-lowering effect, potentially making your blood pressure harder to control.
  • Other weight-loss drugs, stimulants, or herbal diet products: Combining these with phendimetrazine is contraindicated and increases the risk of serious side effects.

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it
  • Do not take phendimetrazine if you have a history of heart disease, coronary artery disease, stroke, heart failure, arrhythmias (abnormal heart rhythms), uncontrolled high blood pressure, or pulmonary hypertension.
  • Do not take it if you have glaucoma (increased eye pressure), an overactive thyroid (hyperthyroidism), or agitated states.
  • Do not take it if you have a history of drug abuse — this medication has abuse potential.
  • Do not take it if you are pregnant or breastfeeding.
  • Tell your doctor if you have a known heart murmur or valvular heart disease — phendimetrazine is not recommended in these cases.
  • Tell your doctor if you have diabetes — your insulin or oral medication needs may change.
  • Do not use phendimetrazine if you have taken any other anorectic (weight-loss) drug within the past year.
  • Tell your doctor about all medications you take — prescription, over-the-counter, and herbal — before starting phendimetrazine.
🚑If you take too much

Taking too much phendimetrazine can cause serious symptoms, including extreme restlessness, confusion, hallucinations, panic, rapid or irregular heartbeat, very high or very low blood pressure, nausea, vomiting, seizures, coma, and in severe cases, death. If you suspect an overdose, call 911 or Poison Control (1-800-222-1222 in the US) immediately.

📡Pharmacodynamics — effects in the body

Phendimetrazine stimulates the central nervous system and raises blood pressure, acting similarly to amphetamines. It is classified as an anorectic — a drug that reduces appetite — though appetite suppression may not be its only weight-loss mechanism. It can also cause rapid heart rate (tachycardia). Tolerance to its appetite-reducing effect typically develops within a few weeks of regular use.

🔬Pharmacokinetics — how your body processes it

Phendimetrazine is eliminated mainly through the kidneys, with most of the drug and its breakdown products excreted in urine. It is partially metabolized into phenmetrazine and phendimetrazine-N-oxide. The average elimination half-life — the time it takes the body to clear half the drug — is about 3.7 hours for both the tablet and extended-release capsule forms. The tablet is absorbed more quickly than the extended-release capsule, which releases the drug gradually over time.

📄 Written from Phendimetrazine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

17

Supplements & herbs that interact with Phendimetrazine

17 supplements and herbal products have documented interactions with Phendimetrazine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 1
  • Moderate · 7
  • Minor · 9
Every supplement checked against Phendimetrazine — ranked by severity The full interaction hub: 1 major · 7 moderate · 9 minor · every one linked to its full report. Check Phendimetrazine against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Phendimetrazine — the kind of thing our pharmacy team would talk through with you at the counter.

What exactly is phendimetrazine supposed to do for me?
Phendimetrazine is a short-term prescription aid to help you lose weight when diet and exercise alone haven't been enough. It's a stimulant that works on your central nervous system — probably by reducing your appetite, though the exact mechanism isn't fully understood. It's meant to be used for just a few weeks as part of a calorie-restricted diet plan, not as a long-term solution on its own.
How do I take it — does it matter when during the day?
It depends on which form you have. If you have the tablet, you'll generally take it about an hour before meals, two or three times a day. If you have the extended-release capsule, you take it just once in the morning — about 30 to 60 minutes before breakfast — and that's it for the day. Don't take it later in the afternoon or evening, because it can seriously interfere with your sleep. Always follow your prescription label and your doctor's exact instructions.
What side effects should I expect, and which ones should make me call my doctor?
Common side effects include dry mouth, trouble sleeping, restlessness, a faster heartbeat, higher blood pressure, dizziness, and nausea. Most of these are related to its stimulant nature. The ones that should make you stop and call your doctor right away are: new shortness of breath with activity, chest pain, fainting, or leg swelling — those can be signs of a serious lung condition called pulmonary hypertension. Also contact your doctor if you experience hallucinations, extreme agitation, or any unusual mental health changes.
Is this medication habit-forming? Can I get addicted?
Yes, phendimetrazine does have real potential for abuse and dependence — it's a stimulant, so this is something to take seriously. Your doctor should only prescribe the minimum amount needed, and you should take it exactly as directed — never more than prescribed. If you have any history of drug or substance abuse, you should not take this medication. If you've been on it for a while at higher doses and want to stop, don't quit abruptly — talk to your doctor first, because stopping suddenly can cause severe fatigue and depression.
Can I take my other medications or supplements while on phendimetrazine?
There are some important interactions to be aware of. The most dangerous one is with MAO inhibitors — a type of antidepressant. Combining them can cause a severe, life-threatening spike in blood pressure, so you must not take phendimetrazine within 14 days of stopping an MAO inhibitor. Alcohol can also cause a bad reaction, so it's best to avoid it. If you take diabetes medications like insulin, your doses may need to be adjusted. And never combine phendimetrazine with any other weight-loss drug, stimulant, or herbal diet supplement — that combination is contraindicated. Always tell your pharmacist and doctor everything you're taking.
Can I take this if I'm pregnant or trying to get pregnant?
No — phendimetrazine is contraindicated in pregnancy, meaning you should not take it if you are pregnant. It's also not recommended if you are breastfeeding. If there's any chance you could become pregnant while taking this medication, talk to your doctor right away so you can discuss your options and next steps.
Is Phendimetrazine available over the counter?
Phendimetrazine is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
Is Phendimetrazine a controlled substance?
Yes — Phendimetrazine is a federally controlled substance (Schedule III) in the United States, so how it is prescribed, refilled and dispensed is regulated by the DEA.
When was Phendimetrazine first available?
Phendimetrazine has been available in the United States since at least 1975, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Phendimetrazine?
Phendimetrazine is supplied by 17 manufacturers listed in the FDA NDC Directory, including Bryant Ranch Prepack, A-S Medication Solutions, Kvk-tech, Inc.

💬 Answers drafted from Phendimetrazine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

💊 How Phendimetrazine comes

Phendimetrazine is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Tablet

By mouth
How this form is used
What it may be used for
  • Phendimetrazine Tartrate tablets are used as a short-term aid for weight loss in adults with a BMI of 30 or higher who have not responded to diet and exercise alone.
  • Phendimetrazine Tartrate tablets are approved for use as monotherapy only — not to be combined with other weight-loss agents or stimulants.
Important instructions
  • Phendimetrazine Tartrate tablets are generally taken two to three times a day, about one hour before meals.
  • Your prescriber may start you on a lower dose to find the amount that works best for you — follow their guidance.
  • Do not exceed the maximum number of tablets per day as directed by your prescriber.
  • Take Phendimetrazine Tartrate tablets at the times prescribed and do not double up if you miss a dose.
Available strengths 1 strength
55 FDA-listed product records

Extended-release capsule

By mouth
How this form is used
What it may be used for
  • Phendimetrazine Tartrate extended-release capsules are used as a short-term aid for weight loss in adults with a BMI of 30 or higher, or 27 or higher with risk factors such as high blood pressure, diabetes, or high cholesterol.
  • Phendimetrazine Tartrate extended-release capsules are approved for use as monotherapy only — not combined with other weight-loss drugs.
Important instructions
  • Phendimetrazine Tartrate extended-release capsules are taken once in the morning, 30 to 60 minutes before the morning meal.
  • Phendimetrazine Tartrate extended-release capsules should not be taken later in the day to avoid sleep problems.
  • Take only one extended-release capsule per day — do not take more than prescribed.
  • Follow your prescriber's directions exactly; do not adjust the dose on your own.
Available strengths 1 strength
8 FDA-listed product records

📊 Phendimetrazine across the U.S. market

How Phendimetrazine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

2
Dose forms
17
Manufacturers
2
Brand names
65
FDA-listed product records
1975
First marketed

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (2) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Bryant Ranch Prepack23%
A-S Medication Solutions20%
Kvk-tech, Inc9%
Preferred Pharmaceuticals Inc.6%
NuCare Pharmaceuticals,Inc.6%
Acertis Pharmaceuticals, LLC5%
Other makers31%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Phendimetrazine is used

A general measure of how commonly Phendimetrazine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Phendimetrazine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

468
Medicaid prescriptions filled (Q1–Q4 2025)
$14,384 gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Phendimetrazine prescribed? Of the 1,596 medications we measure, Phendimetrazine ranks #1,366 by Medicaid prescriptions — more than 14% of them.

Where Phendimetrazine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Phendimetrazine product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 35 mg oral tablet is the most-dispensed Phendimetrazine product — about 78% of these Medicaid prescriptions.

phendimetrazine tartrate 35 MG Oral Tablet Most dispensed

364 Medicaid prescriptions (Q1–Q4 2025) 78% of Phendimetrazine prescriptions shown $4,323 gross reimbursement (before rebates) ≈ $12 per prescription (gross)

Summed across the 2 of 178 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 979549

24 HR phendimetrazine tartrate 105 MG Extended Release Oral Capsule

104 Medicaid prescriptions (Q1–Q4 2025) 22% of Phendimetrazine prescriptions shown $10,060 gross reimbursement (before rebates) ≈ $97 per prescription (gross)

Summed across the 1 of 18 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 979543

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Phendimetrazine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 3 of 196 listed Phendimetrazine NDCs with Medicaid activity.

🔍 Compare Phendimetrazine products

A representative set of FDA-listed product records for Phendimetrazine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 65 of 65 products — FDA National Drug Code Directory. See every product, package size and price: browse all 65 Phendimetrazine NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Phendimetrazine RxCUI 33272 2 dose forms · 2 strengths
  1. Dose form (SCDF) Oral Tablet RxCUI 373306 In current FDA listings
    Clinical drug / strength (SCD) tartrate 35 MG RxCUI 979549

Look up RxCUI 33272 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Melfiat

🏭 Manufacturers & labelers

Bryant Ranch Prepack 15 A-S Medication Solutions 13 Kvk-tech, Inc 6 Preferred Pharmaceuticals Inc. 4 NuCare Pharmaceuticals,Inc. 4 Acertis Pharmaceuticals, LLC 3 Virtus Pharmaceuticals, LLC 3 PD-Rx Pharmaceuticals, Inc. 3 NuCare Pharmaceuticals, Inc. 3 NuCare Pharmaceuticals, Inc, 2 Eon Labs, Inc. 2 Calvin Scott & Co., Inc. 2 Northwind Pharmaceuticals 1 Olon SpA 1 Elite Laboratories, Inc 1 Professional Compounding Centers of America dba PCCA 1 Proficient Rx LP 1

RxNorm drug class

Phendimetrazine belongs to the Sympathomimetic Amine Anorectic class.

Pharmacologic class Sympathomimetic Amine Anorectic

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Dec 19, 2025
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Phendimetrazine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Phendimetrazine after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
17
NDC products indexed
65
Distinct labelers/manufacturers represented
17
Linked representative label
Acertis Pharmaceuticals, LLC
Linked label effective
Dec 19, 2025
Composite sections available
17
Linked SPL Set ID
162140d3-b833-4633-9759-95821a46a690
Linked SPL Document ID
72552285-ab14-4e9f-957a-d913b31bdd84
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 17 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Acertis Pharmaceuticals, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.